Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Phase 2 Study of Aspirin Plus Exemestane Comparing With Exemestane Alone in the Adjuvant Treatment of Postmenopausal Breast Cancer

This is a phase II study to assess efficacy/safety of Exemestane with or without Aspirin as the adjuvant treatment in postmenopausal breast cancer patients.

Inclusion Criteria:

• Breast cancer after surgery postmenopausal

Exclusion Criteria:

• contraindication of aspirin